BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27684979)

  • 21. Diffuse large B-cell lymphomas with plasmablastic differentiation.
    Teruya-Feldstein J
    Curr Oncol Rep; 2005 Sep; 7(5):357-63. PubMed ID: 16091196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall.
    Pan Z; Chen M; Zhang Q; Wang E; Yin L; Xu Y; Huang Q; Yuan Y; Zhang X; Zheng G; Yuan J
    Mod Pathol; 2018 May; 31(5):718-731. PubMed ID: 29327711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary cardiac plasmablastic lymphoma: report of a case and literature review].
    Zhu J; Li Q; Zeng W; Wu Z; Fan L; Xu W; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):862-5. PubMed ID: 26477767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumours.
    Huettl KS; Staiger AM; Horn H; Frontzek F; Goodlad JR; Tapia G; Rosenwald A; Klapper W; Fend F; Climent F; Castellvi J; Tzankov A; Dirnhofer S; Baptista MJ; Navarro JT; Anagnostopoulos I; Hartmann W; Lenz G; Ott G
    Histopathology; 2021 May; 78(6):831-837. PubMed ID: 33165992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis.
    Khan UT; Racu-Amoasii I; Arumainathan A; Meswani U; Pettitt AR; Menon G
    Br J Haematol; 2018 Nov; 183(3):345. PubMed ID: 29984820
    [No Abstract]   [Full Text] [Related]  

  • 26. [Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
    Wang L; Wang W; Li X; Guo Y; Zhu X
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):307-12. PubMed ID: 25030862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary CNS plasmablastic lymphoma in an HIV/EBV negative patient: A case report.
    Romero M; González-Fontal GR; Saavedra C; Guerra J; Quintero G; Quijano S; Ney D; Henao-Martínez AF
    Diagn Cytopathol; 2016 Jan; 44(1):61-5. PubMed ID: 26468050
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasmablastic lymphoma presenting as a large intracardiac mass and bilateral pleural effusions.
    Qing X; Enbom E; Qing A; French S; Cai J
    Exp Mol Pathol; 2016 Feb; 100(1):79-81. PubMed ID: 26607603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmablastic lymphoma and related disorders.
    Hsi ED; Lorsbach RB; Fend F; Dogan A
    Am J Clin Pathol; 2011 Aug; 136(2):183-94. PubMed ID: 21757592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.
    Chen BJ; Yuan CT; Yang CF; Ho CH; Lin YK; Su YZ; Chou HC; Chuang SS
    Virchows Arch; 2022 Aug; 481(2):283-293. PubMed ID: 35657404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics.
    Hansra D; Montague N; Stefanovic A; Akunyili I; Harzand A; Natkunam Y; de la Ossa M; Byrne GE; Lossos IS
    Am J Clin Pathol; 2010 Nov; 134(5):710-9. PubMed ID: 20959653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmablastic lymphoma mimicking carcinomatosis: A case report and review of the literature.
    Olofson AM; Loo EY; Hill PA; Liu X
    Diagn Cytopathol; 2017 Mar; 45(3):243-246. PubMed ID: 27900846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
    Nakaya A; Nagate Y; Toda J; Yamashita Y; Hirose Y; Mori K; Shibayama H
    Rinsho Ketsueki; 2023; 64(4):260-264. PubMed ID: 37121769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmablastic lymphoma: current perspectives.
    Lopez A; Abrisqueta P
    Blood Lymphat Cancer; 2018; 8():63-70. PubMed ID: 31360094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors.
    Guedez L; Martinez A; Zhao S; Vivero A; Pittaluga S; Stetler-Stevenson M; Raffeld M; Stetler-Stevenson WG
    Blood; 2005 Feb; 105(4):1660-8. PubMed ID: 15479729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgA plasmablastic large B-cell lymphoma.
    Roncati L; Maiorana A
    Diagnosis (Berl); 2017 Jun; 4(2):105-107. PubMed ID: 29536914
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma.
    Ahn JS; Okal R; Vos JA; Smolkin M; Kanate AS; Rosado FG
    J Clin Pathol; 2017 Sep; 70(9):775-780. PubMed ID: 28249941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmablastic lymphoma: a clinicopathologic correlation.
    Folk GS; Abbondanzo SL; Childers EL; Foss RD
    Ann Diagn Pathol; 2006 Feb; 10(1):8-12. PubMed ID: 16414538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic features by multiparameter flow cytometry can help distinguish low grade B-cell lymphomas with plasmacytic differentiation from plasma cell proliferative disorders with an unrelated clonal B-cell process.
    Rosado FG; Morice WG; He R; Howard MT; Timm M; McPhail ED
    Br J Haematol; 2015 May; 169(3):368-76. PubMed ID: 25644063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.
    Mori H; Fukatsu M; Ohkawara H; Oka Y; Kataoka Y; Taito S; Ikezoe T
    Int J Hematol; 2021 Dec; 114(6):639-652. PubMed ID: 34462886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.